232 related articles for article (PubMed ID: 31969575)
1. A Common Practice of Widespread Antimicrobial Use in Horse Production Promotes Multi-Drug Resistance.
Álvarez-Narváez S; Berghaus LJ; Morris ERA; Willingham-Lane JM; Slovis NM; Giguere S; Cohen ND
Sci Rep; 2020 Jan; 10(1):911. PubMed ID: 31969575
[TBL] [Abstract][Full Text] [Related]
2. Gallium maltolate as an alternative to macrolides for treatment of presumed Rhodococcus equi pneumonia in foals.
Cohen ND; Slovis NM; Giguère S; Baker S; Chaffin MK; Bernstein LR
J Vet Intern Med; 2015; 29(3):932-9. PubMed ID: 25868480
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy of gallium maltolate for chemoprophylaxis against pneumonia caused by Rhodococcus equi infection in foals.
Chaffin MK; Cohen ND; Martens RJ; O'Conor M; Bernstein LR
Am J Vet Res; 2011 Jul; 72(7):945-57. PubMed ID: 21728856
[TBL] [Abstract][Full Text] [Related]
4. Effect of Macrolide and Rifampin Resistance on the Fitness of Rhodococcus equi.
Willingham-Lane JM; Berghaus LJ; Berghaus RD; Hart KA; Giguère S
Appl Environ Microbiol; 2019 Apr; 85(7):. PubMed ID: 30683740
[No Abstract] [Full Text] [Related]
5. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.
Giguère S; Lee E; Williams E; Cohen ND; Chaffin MK; Halbert N; Martens RJ; Franklin RP; Clark CC; Slovis NM
J Am Vet Med Assoc; 2010 Jul; 237(1):74-81. PubMed ID: 20590498
[TBL] [Abstract][Full Text] [Related]
6. In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi.
Coleman M; Kuskie K; Liu M; Chaffin K; Libal M; Giguère S; Bernstein L; Cohen N
Vet Microbiol; 2010 Nov; 146(1-2):175-8. PubMed ID: 20554401
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors associated with emergence of Rhodococcus equi resistance to macrolides and rifampicin in horse-breeding farms in Kentucky, USA.
Huber L; Giguère S; Cohen ND; Slovis NM; Hanafi A; Schuckert A; Berghaus L; Greiter M; Hart KA
Vet Microbiol; 2019 Aug; 235():243-247. PubMed ID: 31383308
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Infections Caused by Rhodococcus equi.
Giguère S
Vet Clin North Am Equine Pract; 2017 Apr; 33(1):67-85. PubMed ID: 28161038
[TBL] [Abstract][Full Text] [Related]
9. Identification of macrolide- and rifampicin-resistant Rhodococcus equi in environmental samples from equine breeding farms in central Kentucky during 2018.
Huber L; Giguère S; Cohen ND; Slovis NM; Berghaus L; Greiter M; Hart KA
Vet Microbiol; 2019 May; 232():74-78. PubMed ID: 31030848
[TBL] [Abstract][Full Text] [Related]
10. Macrolide- and rifampin-resistant Rhodococcus equi on a horse breeding farm, Kentucky, USA.
Burton AJ; Giguère S; Sturgill TL; Berghaus LJ; Slovis NM; Whitman JL; Levering C; Kuskie KR; Cohen ND
Emerg Infect Dis; 2013 Feb; 19(2):282-5. PubMed ID: 23347878
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Resistance in
Giguère S; Berghaus LJ; Willingham-Lane JM
Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052538
[TBL] [Abstract][Full Text] [Related]
12. Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
Huber L; Giguère S; Slovis NM; Carter CN; Barr BS; Cohen ND; Elam J; Erol E; Locke SJ; Phillips ED; Smith JL
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373803
[TBL] [Abstract][Full Text] [Related]
13. Chemoprophylactic effects of azithromycin against Rhodococcus equi-induced pneumonia among foals at equine breeding farms with endemic infections.
Chaffin MK; Cohen ND; Martens RJ
J Am Vet Med Assoc; 2008 Apr; 232(7):1035-47. PubMed ID: 18380623
[TBL] [Abstract][Full Text] [Related]
14. Effect of Macrolide and Rifampin Resistance on Fitness of
Willingham-Lane JM; Berghaus LJ; Berghaus RD; Hart KA; Giguère S
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331959
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals.
Fines M; Pronost S; Maillard K; Taouji S; Leclercq R
J Clin Microbiol; 2001 Aug; 39(8):2784-7. PubMed ID: 11473992
[TBL] [Abstract][Full Text] [Related]
16. Association between antimicrobial treatment of subclinical pneumonia in foals and selection of macrolide- and rifampicin-resistant
Huber L; Giguère S; Hart KA; Slovis NM; Greiter ME; Dailey CA; Cohen ND
J Am Vet Med Assoc; 2021 Mar; 258(6):648-653. PubMed ID: 33683955
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumonia.
Båverud V; Franklin A; Gunnarsson A; Gustafsson A; Hellander-Edman A
Equine Vet J; 1998 Nov; 30(6):482-8. PubMed ID: 9844966
[TBL] [Abstract][Full Text] [Related]
18. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
Berghaus LJ; Giguère S; Guldbech K
Vet Microbiol; 2013 Oct; 166(3-4):670-5. PubMed ID: 23915992
[TBL] [Abstract][Full Text] [Related]
19. Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi.
Anastasi E; Giguère S; Berghaus LJ; Hondalus MK; Willingham-Lane JM; MacArthur I; Cohen ND; Roberts MC; Vazquez-Boland JA
J Antimicrob Chemother; 2015 Dec; 70(12):3184-90. PubMed ID: 26377866
[TBL] [Abstract][Full Text] [Related]
20. Comparing PFGE, MLST, and WGS in monitoring the spread of macrolide and rifampin resistant Rhodococcus equi in horse production.
Álvarez-Narváez S; Logue CM; Barbieri NL; Berghaus LJ; Giguère S
Vet Microbiol; 2020 Mar; 242():108571. PubMed ID: 32122585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
